RNU6-861P

Across TCGA pan-cancer cohorts, RNU6-861P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-861P data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher RNU6-861P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-861P expression acts as an unfavorable survival marker.

LGG, UCEC, and PAAD are the cancer types where RNU6-861P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Tertile	All	0.151	0.829	<.001	27	view →
UCEC	DFS	Tertile	All	0.123	0.648	.034	18	view →
PAAD	OS	Tertile	All	0.200	0.589	.006	9	view →
STAD	DFS	Tertile	III,IV	0.272	0.612	.035	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-861P–LGG (DFS)

Open the LGG breakdown →